circPVT1 was found to be highly expressed in ER+ breast cancer cells and tumor tissues, promoting ER+ breast tumorigenesis and endocrine resistance via both miRNA sponging and protein scaffolding effects [23]. The gene discussed is ESR1; the disease is neoplasm.